Author(s)

Arifa Akram^1*, Mohammad Jahidur Rahman Khan², Md. Bayzid Bin Monir³, Md. Reaz Uddin Chowdhury⁴, Mahmuda Yeasmin¹, Md. Maruf Ahmed Molla¹, Tasnim Nafisa¹

¹Department of Virology, National Institute of Laboratory Medicine and Referral Center, Dhaka, Bangladesh.
²Department of Microbiology, Shaheed Suhrawardy Medical College, Dhaka, Bangladesh.
³Department of Microbiology, National Institute of Laboratory Medicine and Referral Center, Dhaka, Bangladesh.
⁴Abdul Malek Ukil Medical College, Noakhali, Bangladesh.

With the COVID-19 pandemic, disparities between the infection rate and death rate in different countries become a major concern. In some countries, lower mortality rate compared to others can be explained by better testing capacity and intensive care facilities. Complete SARS-CoV-2 genome sequences from different countries of the world are continually submitted to Global Initiative for Sharing All Influenza Data using Next Generation Sequencing method. A SARS-CoV-2 variant with a D 614G Mutation in the spike (S) protein has become the most dominant form in the global pandemic. There are a number of ongoing studies trying to relate this mutation with the infectivity, mortality, transmissibility of the virus and its impact on vaccine development. This review aims to accumulate the major findings from some of these studies and focus its future implication. Some studies suggested D 614G strain has increased binding capacity, it affects more cells at a faster rate, so has a high transmissibility. Patients infected with this strain were found with high viral load. But still now there is no such evidence that this strain produces more severe disease as well as increased mortality. The structural change of spike protein produced by D 614G mutation was minor and did not hamper the vaccine efficacy. Some studies showed antibodies produced against D614 strain can neutralize G614 strain and vice versa. Whenever a mutation occurs in spike protein there are always chances of affecting the infectivity, transmissibility, vaccine efficacy. Therefore, more studies are required to find out the overall effect of D 614G mutation.

Coronavirus, D 614G Mutation, SARS-CoV-2, Spike Protein, Global Initiative for Sharing All Influenza Data (GISAID)

Akram, A. , Khan, M. , Monir, M. , Chowdhury, M. , Yeasmin, M. , Molla, M. and Nafisa, T. (2020) A Review on D 614G Mutation with Bangladesh Scenario. Advances in Infectious Diseases, 10, 249-255. doi: 10.4236/aid.2020.103024.